Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors

The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome–coronavirus 2 (SARS-CoV-2) is a global health emergency. An attractive drug target among coronaviruses is the main protease (M(pro), also called 3CL(pro)) because of its essential role in processing the poly...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Linlin, Lin, Daizong, Sun, Xinyuanyuan, Curth, Ute, Drosten, Christian, Sauerhering, Lucie, Becker, Stephan, Rox, Katharina, Hilgenfeld, Rolf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2020
Materias:
Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7164518/
https://www.ncbi.nlm.nih.gov/pubmed/32198291
http://dx.doi.org/10.1126/science.abb3405

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7164518/
https://www.ncbi.nlm.nih.gov/pubmed/32198291
http://dx.doi.org/10.1126/science.abb3405

Ejemplares similares